ProfileGDS4459 / ENSG00000196381
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 4% 7% 5% 6% 7% 4% 5% 7% 7% 4% 15% 7% 4% 8% 5% 4% 2% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.434
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.737
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 31.95
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.696
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.247
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.24
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 71.95
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.087
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.027
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 101.914
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.9315
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.987
GSM623476group B, liver allograft wedge biopsie placebo treatment 31.794
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.88
GSM623478group B, liver allograft wedge biopsie placebo treatment 51.95
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.454
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.142